Saboori S, Hosseinzadeh-Attar M J, Yousefi Rad E, Hosseini M, Mirzaei K, Ahmadivand Z
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran; Department of Nutrition and Biochemistry, school of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran; Department of Nutrition and Biochemistry, school of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Diabetes Metab Syndr. 2015 Oct-Dec;9(4):320-3. doi: 10.1016/j.dsx.2013.10.009. Epub 2013 Nov 23.
There is evidence based studies which show that plasma level of visfatin and vaspin in patients with type 2 diabetes mellitus elevate in comparison with healthy people. But there is no consistency in plasma visfatin and vaspin concentration between studies done on obese people. For this reason, the aim of this study is to investigate the serum level concentrations of visfatin and vaspin in obese women compared to normal weight women.
The participants of this study consist of 43 women aged 20-50, and 43 healthy women with normal weight as a control group. They were matched for age and physical activity. 24h food recall was used to collect dietary information from subjects. Moreover, blood sampling was taken to measure the blood levels of sugar, lipid profile, vaspin and visfatin.
The mean serum level of visfatin was not statistically different between obese and normal weight women. But, the obese women had statistically higher mean serum level of vaspin than normal women (p=0.04). We found no relations between serum levels of vaspin with serum concentration of visfatin. Also, serum levels of these two adipokines were not related to the serum concentrations of fasting glucose, total cholesterol, low-density lipoprotein cholesterol and triglyserides and high-density lipoprotein cholesterol. Also, there was a significant positive relationship between carbohydrate intake and serum visfatin level in women participating to this study (p=0.018, r=0.257).
The results of this study demonstrated that the level of serum vaspin was significantly higher in obese women. But there were no differences in serum levels of visfatin in comparison to normal weight women. Meanwhile this study demonstrated a positive relationship between serum levels of visfatin with dietary intake of carbohydrate, but no relationship between serum level of visfatin and vaspin in women participating in this study.
有基于证据的研究表明,2型糖尿病患者的内脂素和内脏脂肪素血浆水平相较于健康人有所升高。但针对肥胖人群的研究中,血浆内脂素和内脏脂肪素浓度并不一致。因此,本研究旨在调查肥胖女性与正常体重女性相比,血清内脂素和内脏脂肪素的水平。
本研究的参与者包括43名年龄在20至50岁之间的女性,以及43名体重正常的健康女性作为对照组。她们在年龄和身体活动方面进行了匹配。采用24小时食物回顾法收集受试者的饮食信息。此外,采集血样以测量血糖、血脂、内脏脂肪素和内脂素的血液水平。
肥胖女性和正常体重女性的内脂素平均血清水平在统计学上无差异。但是,肥胖女性的内脏脂肪素平均血清水平在统计学上高于正常女性(p = 0.04)。我们发现内脏脂肪素的血清水平与内脂素的血清浓度之间没有关系。此外,这两种脂肪因子的血清水平与空腹血糖、总胆固醇、低密度脂蛋白胆固醇、甘油三酯和高密度脂蛋白胆固醇的血清浓度无关。而且,参与本研究的女性碳水化合物摄入量与血清内脂素水平之间存在显著正相关(p = 0.018,r = 0.257)。
本研究结果表明,肥胖女性的血清内脏脂肪素水平显著更高。但与正常体重女性相比,内脂素的血清水平没有差异。同时,本研究表明参与研究的女性血清内脂素水平与碳水化合物饮食摄入量之间存在正相关,但血清内脂素水平与内脏脂肪素水平之间没有关系。